Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

21 Jul 2009 09:21

RNS Number : 0059W
ViaLogy PLC
21 July 2009
 



ViaLogy plc ("ViaLogy")

ViaLogy joins with University of Texas and a large Texas Oil Independen

to analyze oil prospect

LondonJuly 21, 2009Vialogy (LSE: VIY) ViaLogy announces that it has signed a services contract with a large privately owned oil Independent based in MidlandTexas. The company drills over 40 wells per year.  Under this contract ViaLogy will provide reservoir sizing and drilling recommendations for an 11,000 feet deep Strawn formation prospect located in the Midland Basin in the heart of the Wolfberry play. The Wolfberry is currently one of the most active plays in the Permian basin. For competitive reasons the firm has declined to be publicly identified or to provide further project details.

According to the company's Chief Geophysicist"The Strawn formation is one of the more enigmatic hydrocarbon producing stratigraphic formations, as production rates can vary significantly over small regions. Well completion costs are high and we need more innovative computational approaches to characterize the subsurface and develop drilling targets. We are looking forward to ViaLogy's QuantumRD technology to assess subtle porosity variations and size hydrocarbon deposits on our block to mitigate risk."

ViaLogy will be collaborating on this project with seismic expert Prof. Bob Hardage and his geophysics team at the world renowned Bureau of Economic Geology (BEG) at the University of Texas at Austin. Prof. Hardage founded the Exploration Geophysics Laboratory (EGL) (http://www.beg.utexas.edu/indassoc/egl) currently focused on the development and application of multi-component seismic imaging. He has also collaborated with this independent in surveying and analyzing this prospect in the past. Bob Hardage commented, “We are very interested to apply ViaLogy technology to deliver better formation characterization from high quality 3D seismic and multi-component seismic surveys for tight sand-shale sequences. Results could have broad applicability in developing numerous reservoir systems”.

ViaLogy's deliverables will include characterization of hydrocarbon reservoir boundaries, subsurface formations, lithology, and depth, as well as porosity estimates, and recommended drill locations. 

ViaLogy CEO Robert Dean stated, "This is a significant and challenging opportunity to demonstrate our technology with a key independent, and to work hand-in-hand with the prestigious BEG in areas where conventional seismic analysis has proven to be limited. A successful outcome will move us closer to our goal of widespread industry acceptance of QuantumRD. At that point, we will be free to disclose the client and detailed results from the work. Multi-component seismic data is being increasingly collected by the E&P players for high thrust and carbonate reservoirs. Extracting more information from multi-component seismic opens up several new business opportunities for ViaLogy".

Further information from:

ViaLogy

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756) 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy +44 (0) 20-7107-8000 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com.

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEASAFSUSEFW
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.